Logo image
Antidepressant Treatments in Children and Adolescents: II. Anxiety, Physical, and Behavioral Disorders
Journal article

Antidepressant Treatments in Children and Adolescents: II. Anxiety, Physical, and Behavioral Disorders

PAUL J. Ambrosini, MICHAEL D. Bianchi, HARRIS Rabinovich and JOSEPHINE Elia
Journal of the American Academy of Child and Adolescent Psychiatry, v 32(3), pp 483-493
1993
PMID: 8496110

Abstract

antidepressants anxiety behavior disorders physical side-effects
Part II of this review critically evaluates antidepressants' (AD) efficacy in children and adolescents with anxiety, physical, and behavioral disorders as well as AD's side-effect spectrum. AD are administered increasingly to youths with specific anxiety syndromes phenomenologically paralleling those in adults which are responsive to AD (e.g., panic, obsessive-compulsive disorders). While several trials have not substantiated earlier theoretical considerations suggesting their usefulness in separation anxiety, their recent success in ameliorating obsessive-compulsive symptoms is encouraging. Systematic drug treatment studies however are limited because of the common overlap of anxiety syndromes with each other and other prominent psychiatric disturbances. More consistent benefits with AD are seen in the physical (e.g., enuresis, bulimia nervosa) and behavioral disorders (e.g., attention deficit-hyperactivity disorder). The wide-ranging benefits of AD in nonaffective disorders suggest AD are more appropriately viewed as broad spectrum pharmacotherapeutics.

Metrics

10 Record Views
33 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Pediatrics
Psychiatry
Psychology, Developmental
Logo image